Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders

Details for Australian Patent Application No. 2004268207 (hide)

Owner Q Therapeutics, Inc.

Inventors Ramaswami, Mani

Agent David C. Drew

Pub. Number AU-A-2004268207

PCT Pub. Number WO2005/021716

Priority 60/496,830 21.08.03 US

Filing date 20 August 2004

Wipo publication date 10 March 2005

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021716 Priority application(s): WO2005/021716

5 July 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268209-Chamber support for pyrolytic waste treatment system

2004268197-Methods and apparatus for analyzing materials